Printed From BioPortfolio.com
CDC committee favours GSK’s shingles vaccine
03:38 EDT 26 Oct 2017 | PharmaTimes
The US Centre for Disease Control Prevention's Advisory Committee on Immunisation Practices (ACIP) has given its backing to GlaxoSmithKline’s newly approved shingles vaccine Shingrix over Merck & Co’s veteran vaccine Zostavax.
Original Article: CDC committee favours GSK’s shingles vaccine
